Neptune shuffles management suite after recapitalization, continued losses

By Hank Schultz contact

- Last updated on GMT

Neptune shuffles management suite after recapitalization, continued losses
Neptune Technologies and Bioressources is remaking its management team as the company nears reentry into the krill oil marketplace as a producer.  Longtime chief executive officer Henri Harland is out, with chief financial officer Andre Godin named as interim CEO. The news comes on the heels of a recapitalization of the company via a public offering and a subsequent large private placement of shares, and announcement of fourth quarter 2013 results showing continued losses. 

Neptune has struggled to maintain customers and market share since the destruction of its lone production facility in Sherbrooke, Quebec was destroyed in an explosion and subsequent fire in November 2012. The company’s position in connection to its customers and its outstanding contracts was eased somewhat with the announcement of a licensing and supply deal in October, 2013 with the newest entry into the krill oil supply picture, Norway’s Rimfrost.  Neptune is targeting a June reopening of the rebuilt plant.  That, and the resolution of the longstanding patent disputes with competitors Aker BioMarine​ of Norway and Enzymotec of Israel​ means brighter days ahead, Godin said.

“We have a high-tech facility and strong management expertise – which will improve service, encourage innovation and heighten performance – all for the greater good of our employees, customers, and shareholders. On top of this, we have successfully resolved all outstanding litigation issues related to the U.S. International Trade Commission's (ITC) investigation into infringement of Neptune's composition of matter patents. We will now focus on strong execution as we reaffirm our role as a premier krill oil manufacturer in the fast growing omega-3 nutraceutical market,”​ Godin said.

Additional cash

In March, Neptune completed a public offering of shares that netted the company $28 million. Later in April, the company completed a follow-on private placement of shares that bought in an additional $2.5 million.

Neptune-shuffles-management-suite-after-recapitalization-continued-losses_medium
Neptune released this image of its rebuilt production facility.

Harland was one of the co-founders of the company (founded in 1998) and had been involved with the commercialization of krill oil since 1991, according to information from Forbes​ magazine. His tenure saw Neptune complete some of the first studies on the ingredient and be the first to market with krill oil as a human nutrition ingredient, and also saw the company secure the important first patents on krill oil in a number of markets.  Shifts in managment suite personnel are not unusual during times of major capital restructuring, however.

The need for additional captial has been apparent as the company continues to report losses. In the most recent earnings statement, Neptune reported a negative $1.46 million in adjusted EBITDA for the quarter. The company’s financial picture was buoyed by the first royalty payments received under the new licensing agreements with its competitors.  Neptune said it has received $5.5 million in such payments by the end of the quarter which ended Nov. 28, 2014.

Related news

Related products

show more

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals | 09-Oct-2017 | Technical / White Paper

A Brand Owner/Own Label Distributor is 100% responsible for the quality of their products - not the Contract Manufacturing Organization. This is exactly...

Resveratrol – Revitalizing Cognitive Function

Resveratrol – Revitalizing Cognitive Function

Evolva | 29-Sep-2017 | Technical / White Paper

Cognitive decline is fast becoming the biggest concern of the 65+ population. A population which is set to reach 1.1 billion by 2030*.  · 80% of 60+ take...

NattoPharma

12 Reasons MenaQ7® is the Superior Vitamin K2

NattoPharma USA, Inc. | 11-Sep-2017 | Data Sheet

Vitamin K2 as MK-7 supplements are truly changing the face of global health, benefiting old and young alike. We know this because NattoPharma has single-handedly...

Related suppliers

Follow us

Products

View more

Webinars